10/04/23 |
American Association for Cancer Research (AACR) |
AACR MINORITY SCHOLAR IN CANCER RESEARCH AWARDS |
Link |
Foundation |
|
08/29/23 |
FDA |
FDA OWH/CERSI Funding Opportunity |
|
Internal |
|
08/29/23 |
Memorial Sloan Kettering Cancer Center |
Clinical Chemistry Fellowship |
Link |
Foundation |
|
08/29/23 |
American Lung Association |
American Lung Association (various) |
Link |
Foundation |
|
08/29/23 |
DHHS - CDC |
Supporting Young Breast Cancer Survivors, Metastatic Breast Cancer Patients, and their Families |
Link |
DHHS |
Application due: 04/30/24 |
08/29/23 |
NIH |
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
08/29/23 |
NCI |
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/29/23 |
NCI |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings |
Link |
NIH NOSI |
Application due: 11/18/25 |
08/11/23 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings |
Link |
NIH NOSI |
Application due: 11/18/25 |
08/11/23 |
Melanoma Research Alliance |
Melanoma Research Alliance RFP |
Link |
Foundation |
LOI due: 09/20/2023 |
08/11/23 |
NCI |
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
07/27/23 |
NCI |
Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
Link |
NIH NOSI |
Application due: 05/01/25 |
07/27/23 |
NCI |
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments |
Link |
NIH NOSI |
Application due: 05/08/24 |
07/27/23 |
NCI |
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors |
Link |
NIH NOSI |
Application due: 10/09/24 |
07/27/23 |
NCI |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects |
Link |
NIH NOSI |
Application due: 05/09/24 |
07/27/23 |
NCI |
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
07/27/23 |
Cholangiocarcinoma Foundation |
Cholangiocarcinoma Foundation Research Fellowship Program |
Link |
Foundation |
LOI due: 08/11/2023 |
07/11/23 |
NCI |
Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials |
Link |
NIH NOSI |
Application due: 07/01/25 |
06/26/23 |
NCI |
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies |
Link |
NIH NOSI |
Application due: 09/08/26 |
06/12/23 |
NCI |
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) |
Link |
NIH |
|
06/05/23 |
NCI |
Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities |
Link |
NIH NOSI |
Application due: 10/10/26 |
06/05/23 |
NCI |
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers |
Link |
NIH NOSI |
Application due: 07/02/25 |
05/26/23 |
NCI |
Notice of Special Interest (NOSI): Administrative Supplements to Enhance Institutional Data Science Capacity |
Link |
NIH NOSI |
Application due: 04/02/24 |
05/26/23 |
DOD |
FY23 DoD Melanoma Grants |
|
DOD |
|
04/11/23 |
NIH |
Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities |
Link |
NIH NOSI |
Application due: 06/06/26 |
04/11/23 |
UMGCCC |
Student/trainee supplements for PIO faculty to mentor undergraduate or high school trainees |
|
Internal |
|
04/10/23 |
NIH |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health |
Link |
NIH NOSI |
Application due: 05/09/24 |
04/10/23 |
NCI |
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
04/10/23 |
NCI |
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 06/13/24 |
04/10/23 |
NCI |
Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
03/24/23 |
NCI |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects |
Link |
NIH NOSI |
Application due: 05/09/24 |
03/14/23 |
NCI |
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors |
Link |
NIH NOSI |
Application due: 10/09/24 |
03/14/23 |
DOD |
FY23 Ovarian Cancer Research Program (OCRP) (various) |
Link |
DOD |
|
03/14/23 |
The Hope Foundation |
SWOG Trial Support (STrS) |
Link |
Foundation |
|
03/14/23 |
Breast Cancer Alliance |
Breast Cancer Alliance Grants (Various) |
Link |
Foundation |
Application due: 03/31/24 |
03/08/23 |
NCI |
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/17/24 |
03/08/23 |
NCI |
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments |
Link |
NIH NOSI |
Application due: 05/08/24 |
03/08/23 |
NIH |
Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
Link |
NIH NOSI |
Application due: 05/01/25 |
02/28/23 |
NIH |
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers |
Link |
NIH NOSI |
Application due: 07/02/25 |
02/28/23 |
Elsa U. Pardee Foundation |
Elsa U. Pardee Foundation Grant |
Link |
Foundation |
Application due: 12/15/24 |
02/14/23 |
Lung Cancer research Foundation (LCRF) |
LCRF (various) |
Link |
Foundation |
|
02/14/23 |
DOD |
DOD 2023 Breast Cancer Research Program (BCRP) |
Link |
DOD |
|
02/14/23 |
NIH |
Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions |
Link |
NIH NOSI |
Application due: 06/06/26 |
02/14/23 |
NIH |
Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations |
Link |
NIH NOSI |
Application due: 06/06/26 |
02/07/23 |
Prostate Cancer Foundation |
Prostate Cancer Foundation Awards (Various) |
Link |
Foundation |
|
01/24/23 |
V Foundation |
Future V Foundation Opportunities |
|
Internal |
|
01/24/23 |
NIH |
Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute |
Link |
NIH NOSI |
Application due: 11/13/24 |
01/24/23 |
Gray Foundation |
GRAY FOUNDATION BRCA TEAM SCIENCE PROGRAM |
Link |
Foundation |
|
01/24/23 |
NIH |
Notice of Special Interest (NOSI): Adaptive Biomaterials for Cancer Biology |
Link |
NIH NOSI |
Application due: 05/07/25 |
01/24/23 |
NIH |
Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research |
Link |
NIH NOSI |
Application due: 12/31/24 |
01/24/23 |
NIH |
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer |
Link |
NIH NOSI |
Application due: 09/08/24 |
01/09/23 |
Union for International Cancer Control UICC |
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants |
Link |
Foundation |
|
01/09/23 |
NCI |
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
12/20/22 |
NCI |
National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/20/22 |
NCI |
NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/05/22 |
NIH |
Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics |
Link |
NIH NOSI |
Application due: 01/08/26 |
12/05/22 |
NIH |
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/04/22 |
UMB SOM Office of Research Career Development |
Funding for Research on COVID-19 and Information for NIH Applicants re: Impact of COVID-19 on Grants and Submissions |
Link |
COVID |
|
11/04/22 |
UMSOM |
Large Grant Acceleration Program (LGAP) |
Link |
Internal |
|
11/04/22 |
UM VENTURES |
UMCP / UMB Coronavirus Medical Device Challenge Program |
|
COVID |
|
11/04/22 |
NIH |
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection |
Link |
COVID |
|
11/04/22 |
US Department of Veteran Affairs (VA) |
VA opportunities |
Link |
Internal |
Deadline varies by grant |
11/04/22 |
University of Maryland Baltimore, Institute for Clinical & Translational Research (UMB ICTR) |
Special Call for COVID-19 ICTR Voucher Applications |
Link |
COVID |
Applications will be accepted on a rolling basis. |
10/28/22 |
NIH |
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers |
Link |
NOSI |
Application due: 07/02/25 |
10/28/22 |
Cancer Research Institute |
CRI Grants (various) |
Link |
Foundation |
Deadline varies by grant |
10/21/22 |
NCI, NHGRI, NIDCR |
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
10/21/22 |
Pfizer |
2023 Pfizer’s Competitive Grants Program (various) |
Link |
Industry |
Deadline varies by grant |
10/21/22 |
NIH |
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
10/21/22 |
Mesothelioma Applied Research Foundation |
2022 Mesothelioma Research Grant |
Link |
Foundation |
LOI due: 11/21/2022 |
10/21/22 |
NIH |
Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology |
Link |
NIH NOSI |
Application due: 01/08/26 |
10/21/22 |
NCI |
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, 2023 (P50 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
10/21/22 |
NCI |
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
10/14/22 |
NCI |
Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) |
Link |
NIH |
LOI due: 11/28/2022 |
10/14/22 |
NCI |
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
10/14/22 |
NCI |
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
10/14/22 |
NCI |
Notice of Special Interest (NOSI): Expanding Cancer Control Research in Persistent Poverty Areas |
Link |
NOSI |
|